TLDR Aave and Blockdaemon have entered a strategic partnership to expand institutional access to decentralized finance. Aave has been chosen as the exclusive primary lending provider for Blockdaemon’s Earn Stack platform. Institutional clients can now access Aave Vaults to earn staking rewards while maintaining complete control of their assets. The integration enables institutions to access [...] The post Aave and Blockdaemon Unite to Boost Institutional DeFi Participation appeared first on CoinCentral.TLDR Aave and Blockdaemon have entered a strategic partnership to expand institutional access to decentralized finance. Aave has been chosen as the exclusive primary lending provider for Blockdaemon’s Earn Stack platform. Institutional clients can now access Aave Vaults to earn staking rewards while maintaining complete control of their assets. The integration enables institutions to access [...] The post Aave and Blockdaemon Unite to Boost Institutional DeFi Participation appeared first on CoinCentral.

Aave and Blockdaemon Unite to Boost Institutional DeFi Participation

2025/10/10 04:17
3 min read

TLDR

  • Aave and Blockdaemon have entered a strategic partnership to expand institutional access to decentralized finance.
  • Aave has been chosen as the exclusive primary lending provider for Blockdaemon’s Earn Stack platform.
  • Institutional clients can now access Aave Vaults to earn staking rewards while maintaining complete control of their assets.
  • The integration enables institutions to access over $70 billion in on-chain liquidity.
  • Blockdaemon customers can utilize idle balances across DeFi markets, supported by Bitcoin, Ethereum, and stablecoins.

Aave and Blockdaemon have launched a strategic partnership to expand institutional access to decentralized finance (DeFi) lending and staking. The collaboration enables institutional clients to integrate Aave’s DeFi protocols with Blockdaemon’s infrastructure via its Earn Stack platform. The integration unlocks secure yield opportunities, staking rewards, and access to over $70 billion in on-chain liquidity.

Aave Becomes Primary Lending Provider for Blockdaemon’s Earn Stack

Aave will serve as the exclusive lending protocol for Blockdaemon’s Earn Stack, a non-custodial staking and yield platform. This platform supports over 50 blockchain protocols and enables secure staking with institutional-grade controls. Through this integration, clients can access DeFi lending without compromising custody or compliance.

Blockdaemon selected Aave due to its long-standing operational resilience and robust risk frameworks, which meet institutional standards. Aave’s reputation in DeFi provides reliable lending access for customers requiring consistent and secure infrastructure. As a result, institutions can utilize idle balances and staking rewards across top digital assets, such as Bitcoin and Ethereum.

“This partnership opens new avenues for growth across crypto assets and stablecoins,” said Konstantin Richter, Blockdaemon’s CEO. Institutions can tap into DeFi lending directly through familiar infrastructure, allowing them to leverage their existing resources. The collaboration underscores Aave’s growing role as a cornerstone in institutional DeFi markets.

Integration Unlocks Access to Aave Vaults and Tokenized Assets

The integration leverages Aave Vaults to provide institutional staking and lending services while maintaining asset control. Vaults enable users to earn rewards by interacting directly with DeFi lending strategies within the Aave protocol. Institutions gain streamlined access without compromising security or liquidity.

Aave’s on-chain lending markets provide deep liquidity and attractive yields through direct interaction with stablecoins and digital assets. The inclusion of Aave Vaults ensures strategic yield generation for institutional balances that are idle. As a result, clients can maximize returns while meeting regulatory expectations.

Supported assets include leading stablecoins, such as USDC, RLUSD, and GHO, as well as tokenized assets like USTB and JTRSY. These assets are now accessible through Blockdaemon’s Earn Stack and the Horizon market. This unlocks capital efficiency while allowing borrowing against real-world asset collateral.

Horizon Market Integration Expands Real-World Asset Access

Blockdaemon’s integration with Horizon, a market focused on tokenized real-world assets (RWAs), strengthens Aave’s institutional reach. Launched in August 2025, Horizon has surpassed $200 million in total value locked. The platform facilitates borrowing against RWAs using stablecoins like GHO and RLUSD.

Users deposit stablecoins and tokenized assets into Aave-supported RWA pools. These assets serve as collateral for borrowing activity within Aave’s lending protocol. This structure maintains decentralization while enabling real-world financial exposure.

Aave’s involvement ensures that borrowers have access to trusted DeFi liquidity, while lenders earn secure on-chain yields. The Horizon market’s rapid growth aligns with rising demand for RWA exposure. Institutions now have streamlined access to tokenized financial products through trusted platforms.

The post Aave and Blockdaemon Unite to Boost Institutional DeFi Participation appeared first on CoinCentral.

Market Opportunity
AaveToken Logo
AaveToken Price(AAVE)
$109.48
$109.48$109.48
-2.77%
USD
AaveToken (AAVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26